NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 147 filers reported holding NEKTAR THERAPEUTICS in Q2 2014. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,317,000 | +105.3% | 179,877 | +67.2% | 0.02% | +112.5% |
| Q2 2017 | $2,103,000 | +8.4% | 107,555 | +30.1% | 0.01% | 0.0% |
| Q1 2017 | $1,940,000 | +78.5% | 82,680 | -6.7% | 0.01% | +60.0% |
| Q4 2016 | $1,087,000 | -24.5% | 88,587 | +5.7% | 0.01% | -16.7% |
| Q3 2016 | $1,440,000 | +19.6% | 83,846 | -0.9% | 0.01% | +20.0% |
| Q2 2016 | $1,204,000 | +1.2% | 84,618 | -0.6% | 0.01% | 0.0% |
| Q1 2016 | $1,190,000 | -18.4% | 85,166 | -1.6% | 0.01% | -16.7% |
| Q4 2015 | $1,459,000 | +57.1% | 86,558 | +2.1% | 0.01% | +50.0% |
| Q3 2015 | $929,000 | -13.1% | 84,777 | -0.8% | 0.00% | 0.0% |
| Q2 2015 | $1,069,000 | -15.5% | 85,453 | -25.7% | 0.00% | -20.0% |
| Q1 2015 | $1,265,000 | -30.8% | 114,971 | -2.6% | 0.01% | -37.5% |
| Q4 2014 | $1,829,000 | +29.7% | 117,995 | +1.0% | 0.01% | +33.3% |
| Q3 2014 | $1,410,000 | -5.7% | 116,820 | +0.1% | 0.01% | 0.0% |
| Q2 2014 | $1,496,000 | +7.2% | 116,710 | +1.3% | 0.01% | 0.0% |
| Q1 2014 | $1,396,000 | +14.0% | 115,181 | +6.7% | 0.01% | +20.0% |
| Q4 2013 | $1,225,000 | +7.3% | 107,963 | -1.2% | 0.01% | 0.0% |
| Q3 2013 | $1,142,000 | +13.1% | 109,305 | +25.0% | 0.01% | 0.0% |
| Q2 2013 | $1,010,000 | – | 87,456 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |